Reviva Pharmaceuticals (RVPH) Q4 2025 Earnings

13NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-1.89
-1.3
-0.71
-0.12

Details

Expected EPS
-1.894571
Actual EPS
-1.2
Surprise EPS
0.69
Surprise Percent
+36.66%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of -1.2 per share for Q4 2025.

0 Comments

Share your thoughts